CHG-2021-0180
Formulation Change for Mavacamtamex. Formulation Change for Mavacamtamex — critical change. Impacts 7 markets and 1 variations.
Change Number
CHG-2021-0180
Type
Formulation Change
Product
Status
In Progress
Owner
Nadia Petrova
Initiated
2023-10-21
Description
Formulation Change for Mavacamtamex — critical change
Impacted Markets (7)
EU — European UnionBR — BrazilTR — TurkeyZA — South AfricaPL — PolandBE — BelgiumAT — Austria
Impacted Modules
3.2.P.32.3.P4.2.1
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|